The North America Respiratory Care Devices Market was valued at USD 7,325 million in 2025 and is projected to reach USD 16,210 million by 2035, expanding at a CAGR of 7.5% from 2024 to 2035. The market is driven by the rising incidence of chronic respiratory diseases, technological innovations and a rapidly aging population, especially in the United States and Canada.
The economic impact of tariffs on "North America Respiratory Care Devices Market".
Market Growth Drivers
Increasing Prevalence of Chronic Respiratory Diseases: The market is experiencing robust growth due to the rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea. According to Philips, the demand for devices such as ventilators and nebulizers witnessed a significant surge during the COVID-19 pandemic and remains elevated as healthcare systems become more proactive in managing chronic cases. The increasing awareness and screening efforts are further fueling the adoption of advanced respiratory care devices.
Technological Advancements in Portable Devices: Leading companies like ResMed have been investing in technological advancements that enhance the portability and efficiency of respiratory care devices. The introduction of compact, battery-powered devices has enabled better patient mobility, particularly for home care use. The surge in telehealth integration allows continuous monitoring of patient health, which is driving product adoption across homecare and clinical settings.
Market Trends
Integration of Artificial Intelligence (AI): Companies such as Medtronic are embedding AI-driven analytics within their respiratory care solutions. These smart devices monitor real-time patient data, predict exacerbations, and provide clinical decision support, resulting in improved patient outcomes and streamlined hospital workflows. This trend is expected to revolutionize respiratory care by enabling early interventions and personalized therapy adjustments.
Rising Preference for Homecare Devices: There is a notable shift towards home-based respiratory care driven by patient preference, cost savings, and advances in user-friendly device design. Companies like Vyaire Medical have expanded their portfolio of compact CPAP and BiPAP machines tailored for home use to cater to this trend. Increased insurance coverage for at-home respiratory therapies further supports this shift.
Market Opportunities
Expansion into Digital Health Platforms: There is significant opportunity for market players to integrate their respiratory devices with digital health platforms and apps. Companies like Philips can leverage AI and remote monitoring technology to enhance the continuum of care, extend market reach, and support real-time patient management.
Emerging Markets within North America: Regional expansions into underserved areas, such as rural U.S. states and Mexico, present sizeable growth opportunities for companies like Fisher & Paykel Healthcare, as they aim to address the unmet needs for respiratory care.
North America Respiratory Care Devices Market Revenue (USD Million), 2020-2035
The chart illustrates steady and significant growth in the North America Respiratory Care Devices Market from 2020 to 2035. Starting at USD 5,500 million in 2020, the market climbs to USD 7,325 million by 2025 and then exhibits accelerated growth to reach approximately USD 16,210 million in 2035. Key drivers include the increased burden of chronic respiratory diseases, rising elderly population and technological advancement. The steady CAGR of around 7.5% highlights sustained investment and innovation, while the curve’s sharper ascent post-2025 evidences intensifying adoption of homecare and AI-integrated devices. The growth is evenly distributed but is expected to pick up momentum post-2030 as digital therapeutics and remote monitoring become more mainstream.
North America Respiratory Care Devices Market by Regions Share (%), 2025
The pie chart outlines the market share distribution across North America for the year 2025. The United States holds the dominant share with 78%, reflecting its advanced healthcare infrastructure, high prevalence of respiratory conditions, and strong adoption of new technologies. Canada follows with a 14% share due to its increasing focus on respiratory health and aging population. Mexico, with 5%, is emerging as a key growth market driven by rising disease incidence and investments in healthcare. Rest of North America, comprising smaller countries and territories, accounts for 2% (Caribbean) and 1% (Bermuda & Others) respectively, indicating nascent but potentially growing markets as awareness and access expand.
Recent Developments (Last 6 Months)
In March 2024, ResMed announced the launch of its newest portable ventilator, AirMini Pro, throughout the United States and Canada. This device features enhanced battery life and integrates seamlessly with the ResMed app for remote patient monitoring, reflecting ResMed’s commitment to homecare innovation.
In April 2024, Philips received FDA clearance for its AI-powered Trilogy Evo ventilator, which includes predictive analytics to help clinicians anticipate and manage acute respiratory events. This breakthrough is expected to improve patient care in both acute and chronic settings and underscores Philips’ leadership in AI-enabled respiratory care solutions.
In May 2024, Fisher & Paykel Healthcare expanded its manufacturing facility in Tijuana, Mexico, to meet the growing demand for respiratory care devices across North America. The expansion is projected to increase production capacity by 30%, ensuring faster delivery and supply chain resilience as the company targets new healthcare contracts in Mexico and southern US states.
Press Releases